|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 5 of 24 found articles
| Title: |
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial |
| Author: |
Kawashima, Yosuke Fukuhara, Tatsuro Saito, Haruhiro Furuya, Naoki Watanabe, Kana Sugawara, Shunichi Iwasawa, Shunichiro Tsunezuka, Yoshio Yamaguchi, Ou Okada, Morihito Yoshimori, Kozo Nakachi, Ichiro Seike, Masahiro Azuma, Koichi Kurimoto, Futoshi Tsubata, Yukari Fujita, Yuka Nagashima, Hiromi Asai, Gyo Watanabe, Satoshi Miyazaki, Masaki Hagiwara, Koichi Nukiwa, Toshihiro Morita, Satoshi Kobayashi, Kunihiko Maemondo, Makoto |
| Appeared in: |
Lancet respiratory medicine |
| Paging: | Volume 10 () nr. 1 pages 72-82 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 5 of 24 found articles
| << previous | next >> |